Hair loss risk goes up on GLP-1 drugs, BMJ study finds: The BMJ study examined over 50,000 people with Type 2 diabetes taking GLP-1 receptor stimulants, comparing them with patients using other diabetes drugs such as SGLT-2 and DPP-4. #HairLoss #Diabetes #GLP1 #HealthNews #BMJStudy

Discover more from UM LEGACY PRESS LTD

Subscribe now to keep reading and get access to the full archive.

Continue reading